<?xml version="1.0" encoding="ISO-8859-1"?>

<?xml-stylesheet type="text/css" href="https://www.webwire.com/includes/rssstyle.css"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
  
  <!-- Issuers of news/press releases and NOT WebWire are solely responsible for the accuracy of the content. -->



    <title>WebWire | News by Industry : Biotechnology</title>
    <link>https://www.webwire.com/</link>
    <description>Biotechnology News by WebWire</description>
    <language>en-US</language>
    <copyright>Copyright &#169; 2026 WebWire. All Rights Reserved.</copyright>
    <ttl>15</ttl>
    <lastBuildDate>Sun, 23 Aug 2026 02:12:26 EDT</lastBuildDate>
	<image>
      <title>WebWire | News by Industry : Biotechnology</title>
      <width>140</width>
      <height>32</height>
      <link>https://www.webwire.com/</link>
      <url>https://www.webwire.com/imgs/webwire_logo_140x32.gif</url>
    </image>
	

  <item>
     <title>dsm-firmenich initiates patent infringement litigation in China regarding production of Sclareol via biotechnology</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=359298</link>
     <pubDate>Fri, 21 Aug 2026 14:05:53 EDT</pubDate>
     <description><![CDATA[<p> dsm-firmenich, innovators in nutrition, health, and beauty, has initiated patent infringement litigation before the Xiong&#39;An New District Court of Hebei Province, China, against multiple Chinese entities, including a sclareol producer and a research institute. The legal petition alleges the unauthorized use of dsm-firmenich&#39;s patent for the production of sclareol - a valuable intermediate in the production of amber ingredients such as Ambrox&#174; Super. dsm-firmenich requested that the Court o...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=359298">https://www.webwire.com/ViewPressRel.asp?aId=359298</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/359298/359298-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID359298</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Cell-preservation technique could make CAR-T cell therapy more accessible</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=359252</link>
     <pubDate>Fri, 21 Aug 2026 12:03:30 EDT</pubDate>
     <description><![CDATA[<p> Immune cells that are engineered to attack cancer cells, known as CAR-T cells, are used to treat some types of blood cancer. However, only about 5 percent of hospitals in the United States have the ability to generate and deliver CAR-T cells to patients. For many patients, this means the cells need to be frozen and shipped long-distance. -   -  To help make this type of therapy accessible to more people, researchers at MIT have developed a new way to protect the cells from damage that can occu...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=359252">https://www.webwire.com/ViewPressRel.asp?aId=359252</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/359252/359252-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID359252</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Robert Reyes Challenges Conventional Neural Theory of Vision With a Holographic Framework at MIBF 2026</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=358858</link>
     <pubDate>Thu, 13 Aug 2026 17:08:02 EDT</pubDate>
     <description><![CDATA[<p> Independent researcher and author Robert Reyes will have his book,  &#8220;The Human Holographic Visual System,&#8221;  showcased at the 2026 Manila International Book Fair, bringing a provocative question to readers: does the prevailing neural theory fully explain how visual images are produced in the brain? -   -  Reyes recently submitted an article to  Skeptical Inquirer Magazine  and is developing a longer work-in-progress article for  Frontier Magazine. His central message is that the current neural...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=358858">https://www.webwire.com/ViewPressRel.asp?aId=358858</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/104593/358858/358858-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID358858</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Building the New: How a Lyme Patient Advocate Landed in the NIH Director&#39;s Office</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=358724</link>
     <pubDate>Thu, 13 Aug 2026 09:00:00 EDT</pubDate>
     <description><![CDATA[<p> At 7:00 a.m. on Monday, March 16, 2026, Bruce Fries, President of the Patient Centered Care Advocacy Group, emailed NIH Director Dr. Jay Bhattacharya with a comprehensive proposal:  Strengthening NIH Research Standards: A Framework for Scientific Integrity, Transparency and Stakeholder Engagement. -   -  Eighty minutes later, Bhattacharya wrote back himself, thanking Fries and asking to meet. Four days later, Fries was in the Director&#39;s office at NIH headquarters, just the two of them, talking...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=358724">https://www.webwire.com/ViewPressRel.asp?aId=358724</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/48616/358724/358724-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID358724</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>ConV2X Announces Cross Sector Executive Speaker Roster for NYC Executive Health Tech Summit</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=358674</link>
     <pubDate>Mon, 10 Aug 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> Partners in Digital Health has announced the confirmed speaker lineup for ConV2X 2026: Smart Technology Transformation in Healthcare, taking place October 29&#8211;30, 2026, at the ILR Conference Center, 570 Lexington Avenue in New York City. The two day executive summit will convene leaders responsible for implementing artificial intelligence, virtual care, data intelligence, connected health technologies and new healthcare delivery models. -   -  ConV2X is designed for executives seeking more than...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=358674">https://www.webwire.com/ViewPressRel.asp?aId=358674</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/358674/358674-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID358674</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Coalition for Decentralized Healthcare and Life Sciences Recognized by United Nations Global Dialogue on AI Governance</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=358150</link>
     <pubDate>Mon, 27 Jul 2026 08:30:00 EDT</pubDate>
     <description><![CDATA[<p> The Coalition for Decentralized Healthcare and Life Sciences (CDHLS) announces its recognition as a featured initiative on the United Nations Global Dialogue on AI Governance Partnerships Hub, positioning the coalition as a global stakeholder in shaping the future of artificial intelligence governance in healthcare and life sciences. -   -  CDHLS&#39;s initiative, &#8220;Decentralized Health Systems Adoption at Scale,&#8221; is listed under three of the Global Dialogue&#39;s thematic clusters: Bridging AI Divides...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=358150">https://www.webwire.com/ViewPressRel.asp?aId=358150</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/358150/358150-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID358150</guid>
     <dc:type>Article</dc:type>
  </item>

  </channel>
</rss>
